Comparison of the Effect of Pyridostigmine and Sugammadex on Emergence Delirium in Pediatric Patients Undergoing Strabismus Surgery: A Randomized Controlled Trial
Related Experiment Videos
Chung-Sik Oh1,2,3, Hyun Jin Shin2,3,4, Seon-Ju Park1
1Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, Seoul 05030, Republic of Korea.
Insights
Emergence delirium (ED) in pediatric patients after anesthesia was similar whether pyridostigmine or sugammadex was used for reversal. Neither agent significantly impacted ED incidence or severity in strabismus surgery patients.
Area of Science:
- Anesthesiology
- Pediatric Surgery
- Pharmacology
Background:
- Emergence delirium (ED) is a frequent complication in children post-general anesthesia.
- Reduced cholinergic neurotransmission is linked to cognitive deficits and increased delirium risk.
- Pediatric strabismus surgery is a common procedure where ED can occur.
Purpose of the Study:
- To compare the incidence of ED after using a cholinesterase inhibitor (pyridostigmine) versus sugammadex for neuromuscular blockade reversal.
- To evaluate the impact of different neuromuscular reversal agents on ED in pediatric patients undergoing strabismus surgery.
Main Methods:
- A randomized study involving 76 pediatric patients (aged 4-7 years) undergoing strabismus surgery.
- Patients were allocated to receive either pyridostigmine (Group P) or sugammadex (Group S) for neuromuscular blockade reversal.
- The Pediatric Anesthesia Emergence Delirium (PAED) scale was used to assess ED, defined as a score ≥ 10.
Main Results:
- The incidence of ED was 50.0% in the pyridostigmine group and 40.5% in the sugammadex group (p=0.417).
- Peak PAED scores were not significantly different between the two groups (p=0.277).
- The study included 73 patients who completed the assessment.
Conclusions:
- The choice of neuromuscular reversal agent (pyridostigmine vs. sugammadex) did not significantly alter the incidence or severity of emergence delirium.
- These findings suggest that current reversal strategies do not differentially impact ED in this pediatric population undergoing strabismus surgery.
Abstract:
Background: Emergence delirium (ED) is a common complication in pediatric patients following general anesthesia. Reduced cholinergic neurotransmission is closely associated with cognitive impairment and an increased risk of delirium. This study aimed to compare the effects of a cholinesterase inhibitor versus sugammadex-used as neuromuscular blockade reversal agents-on the incidence of ED following pediatric strabismus surgery. Methods: Seventy-six patients, aged 4-7 years, were enrolled and randomly allocated to either the pyridostigmine group (Group P) or the sugammadex group (Group S). The dose of each agent was determined according to the train-of-four count or ratio. The Pediatric Anesthesia Emergence Delirium (PAED) scale was assessed at 15-min intervals in the post-anesthesia care unit until the score fell below 10. ED was defined as a PAED score ≥ 10. Results: Of the 73 patients who completed the study, 36 were in Group P, and 37 were in Group S. The incidence of ED was 50.0% in Group P and 40.5% in Group S (odds ratio = 0.682; 95% confidence interval = 0.270-1.721; p = 0.417). The peak PAED scores were 10.0 (7.0, 15.5) in Group P and 9.0 (7.5, 11.5) in Group S (median [interquartile range]; p = 0.277). Conclusions: The choice of neuromuscular reversal agent did not significantly affect the incidence of ED in pediatric patients undergoing strabismus surgery.
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...